Dachaigh › Tiotalan dreuchd › Senior Biostatistician
Senior Biostatistician: Tuarastalan H-1B
Chleachd 110 iarrtasan cumhaichean-obrach an tiotal dreuchd Senior Biostatistician. Tuarastal bunasach meadhanach $123,674; leth meadhanach $93,870–$138,474.
Iarrtasan (LCAs)110
Tuarastal meadhanach a chaidh a thabhann$123,674
Leath mheadhanach nan tuarastalan$93,870–$138,474
Ceudail 10mh–90mh$81,950–$148,103
Laghiche in-imrich, neach-faighinn no neach-fastaidh? Seall do sheirbheis aig mullach na duilleige seo — $99 airson 30 latha →
Luchd-fastaidh
| Neach-obrach | LCAs | Tuarastal meadhanach |
|---|
| IQVIA RDS Inc. | 9 | $139,322 |
| Vanderbilt University Medical Center | 7 | $93,000 |
| Cytel Inc. | 6 | $135,000 |
| Daiichi Sankyo, Inc. | 6 | $141,386 |
| Baylor College of Medicine | 6 | $90,000 |
| Natera, Inc. | 6 | $128,361 |
| Cleveland Clinic Foundation | 5 | $72,301 |
| Syneos Health, LLC | 5 | $110,000 |
| Parexel International LLC | 4 | $133,606 |
| TechData Service Company LLC | 4 | $145,000 |
| St. Jude Children's Research Hospital | 3 | $93,870 |
| Foundation Medicine, Inc. | 3 | $137,966 |
| Fortrea Inc. | 3 | $99,861 |
| Redbock LLC | 3 | $137,280 |
| Health Research Inc. - Roswell Park Division | 2 | $96,559 |
| CareDx, Inc | 2 | $144,821 |
| Ionis Pharmaceuticals, Inc. | 2 | $100,222 |
| Axio Research, LLC | 2 | $108,962 |
| ClinChoice Inc. | 2 | $122,282 |
| Mount Sinai Hospital | 2 | $102,182 |
| PreciseDx, Inc. | 2 | $180,000 |
| Alexion Pharmaceuticals, Inc. | 2 | $141,400 |
| Fulcrum Therapeutics, Inc. | 1 | $115,000 |
| Tempus Labs, Inc. | 1 | $135,000 |
| WCG Clinical, Inc. | 1 | $59,155 |
| Adventist Health System/Sunbelt, Inc. | 1 | $83,241 |
| Abbott Molecular Inc. | 1 | $86,000 |
| NJS Associates Company | 1 | $165,000 |
| NYU Grossman School of Medicine | 1 | $137,800 |
| Pharmaron US Clinical Services, Inc. | 1 | $75,000 |
| Safety & Efficacy IT Solutions Inc. | 1 | $103,000 |
| BeiGene USA, Inc. | 1 | $135,000 |
| Thomas Jefferson University | 1 | $90,000 |
| Roche Molecular Systems, Inc. | 1 | $124,238 |
| General Hospital Corporation | 1 | $87,246 |
| Karyopharm Therapeutics Inc. | 1 | $187,044 |
| Sanofi Pasteur Inc. | 1 | $100,500 |
| Cerus Corporation | 1 | $150,000 |
| Beckman Coulter, Inc. | 1 | $111,375 |
| Biosense Webster, Inc. | 1 | $145,000 |
| Zimmer, Inc. | 1 | $127,810 |
| Abbott Diabetes Care Inc. | 1 | $123,000 |
| Everest Clinical Research Corporation | 1 | $130,000 |
| Cardiovascular Research Foundation | 1 | $119,000 |
| BeOne Medicines US Manufacturing Co., Inc. | 1 | $144,200 |
| Medical Device Business Services, Inc. | 1 | $130,000 |
A rèir ìre tuarastail
| Ìre tuarastail | Tuarastal meadhanach |
|---|
| Ìre I (innte) | $92,500 |
| Ìre II (càileachail) | $123,000 |
| Ìre III (eòlach) | $135,352 |
| Ìre IV (gu lèir comasach) | $159,000 |
Suidhichidh Roinn an Obrach ceithir ìrean tuarastail làithreach airson gach dreuchd agus sgìre, bho Ìre I (inntrigeadh) gu Ìre IV (gu tur comasach). Taghaidh an neach-fastaidh an ìre a fhreagras ri riatanasan na h-obrach.
A rèir bliadhna ionmhais
| Bliadhna mhaoine | LCAs | Tuarastal meadhanach |
|---|
| FY2023 | 30 | $114,462 |
| FY2024 | 27 | $112,258 |
| FY2025 | 33 | $127,810 |
| FY2026 | 18 | $127,500 |
Bailtean
- Houston, TX7
- Nashville, TN6
- Basking Ridge, NJ6
- Cleveland, OH5
- New York, NY4
- Memphis, TN3
- Medford, MA3
- Bellevue, WA3
- Durham, NC3
- Jersey City, NJ3
- Buffalo, NY2
- Billerica, MA2
- Cambridge, MA2
- Carlsbad, CA2
- Fort Washington, PA2
- Seattle, WA2
- San Jose, CA2
- New Haven, CT2
- San Carlos, CA2
- King of Prussia, PA2
- Irvine, CA2
- West Lafayette, IN1
- Raritan, NJ1
- Los Angeles, CA1
- Seabrook, TX1
- Orlando, FL1
- Foster City, CA1
- North Billerica, MA1
- Rockville, MD1
- Des Plaines, IL1
Is e na tuarastalan an ìre as ìsle den tuarastal a chaidh a thabhann air gach iarrtas, air an tionndadh gu suim bhliadhnail; cleachdaidh na staitistigean iarrtasan làn-aimsire le teisteanas a-mhàin. Chan eil LCA na aontachadh bhìosa agus faodaidh aon LCA còmhdach a dhèanamh air iomadh dreuchd. Stòr: Roinn an Obrach na SA, Dàta Foillseachaidh OFLC LCA, bliadhnaichean ionmhais 2023–2026 (co-dhùnadh as ùire 30 Ògmh 2026).